Bristol Myers Squibb (CELG-RI) Preferred Shares (2009 - 2019)
Bristol Myers Squibb's (CELG-RI) quarterly Preferred Shares came in at $10.0 million in Q4 2019, little changed quarter-over-quarter from $10.0 million in Q3 2010.
Powered by 
Analysis
Bristol Myers Squibb (CELG-RI) Preferred Shares (2009 - 2019) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has reported Preferred Shares for 3 consecutive years, with $10.0 million the latest figure, recorded in Q4 2019.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $10.0 million in Q4 2019; TTM through Dec 2019 was $10.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $10.0 million, changed 0.0% from the prior year.
- Preferred Shares was $10.0 million for Q4 2019 at Bristol Myers Squibb, roughly flat from $10.0 million in the prior quarter.
- Over five years, Preferred Shares peaked at $10.0 million in Q4 2019 and troughed at $10.0 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.37 Bn | 621.61 Bn | 17.26 Bn | - |
| 2 | AbbVie | 446.97 Bn | 440.40 Bn | 12.70 Bn | - |
| 3 | Merck | 357.93 Bn | 350.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.54 Bn | 259.85 Bn | 11.24 Bn | - |
| 5 | Pfizer | 156.64 Bn | 144.94 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.21 Bn | 44.83 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.91 Bn | 42.91 Bn | - | - |
| 8 | Incyte | 24.61 Bn | 20.08 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Bristol Myers Squibb | 232.18 Mn | -10.83 Bn | 9.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 10.00 Mn |
| Sep 30, 2010 | 10.00 Mn |
| Jun 30, 2010 | 10.00 Mn |
| Mar 31, 2010 | 10.00 Mn |
| Dec 31, 2009 | 10.00 Mn |